Log off SitemapDisclaimer

Treatment of chronic pain - Matrifen® from Nycomed

Treatment of chronic pain with Matrifen® from Nycomed is indicated for patients with severe chronic pain such as cancer pain or low back pain.

Treatment of chronic pain with Matrifen® by NycomedTreatment of chronic pain is much more efficient with Matrifen® - the transdermal patch which relieves pain in patients with prolonged or chronic severe pain.

>> Information on treatment of chronic pain

Matrifen® pain relief patch provides a 3 day treatment of chronic pain with a relatively low drug load for a higher degree of safety.

The treatment of chronic pain with the Matrifen® transdermal fentanyl patch is mainly for patients with chronic pain such as cancer pain, low back pain, naturopathic pain, nociceptive pain and other chronic pains.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table